Quetiapine XR for Cognitive and Functional Disability in Clinically Stable Patients With Bipolar Disorder

PHASE4TerminatedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Bipolar DisorderCognitive Impairment
Interventions
DRUG

Quetiapine XR

oral doses, 200 mg, 300 mg, 400 mg

DRUG

Placebo

200mg, 300mg or 400mg

Trial Locations (2)

27710

Duke University, Durham

30322

Emory University School of Medicine, Atlanta

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Duke University

OTHER

collaborator

University of Toronto

OTHER

lead

Emory University

OTHER